The chemiluminescence from four cyclometalated iridium(III) complexes containing an ancillary bathophenanthroline-disulfonate ligand exhibited a wide range of emission colours (green to red), and in some cases intensities that are far greater than the commonly employed benchmark reagent, [Ru(bpy)3](2+). A similar complex incorporating a sulfonated triazolylpyridine-based ligand enabled the emission to be shifted into the blue region of the spectrum, but the responses with this complex were relatively poor. DFT calculations of electronic structure and emission spectra support the experimental findings.

Tuberculosis (TB) remains a pressing unmet medical need, particularly with the emergence of multidrug-resistant and extensively drug-resistant tuberculosis. Here, a series of 1,4-substituted-1,2,3-triazoles have been synthesized and evaluated as potential antitubercular agents. These compounds were assembled via click chemistry in high crude purity and in moderate to high yield. Of the compounds tested, 12 compounds showed promising antitubercular activity with six possessing minimum inhibitory concentration (MIC) values <10 μg mL(-1) , and total selectivity for Mycobacterium tuberculosis (Mtb) growth inhibition. A second set of 21 compounds bearing variations on ring C were synthesized and evaluated. This second library gave an additional six compounds displaying MIC values ≤10 μg mL(-1) and total selectivity for Mtb growth inhibition. These compounds serve as an excellent starting point for further development of antitubercular therapies.

No abstract

This highlight solely focusses on the synthetic applications of azavinyl rhodium(II) carbenes derived from N-sulfonyl triazoles. An overview of their use in intermolecular reactions to form a variety of heterocycles is examined, in addition to intramolecular annulations and rearrangements.

The inside cover picture shows that 30 % of the world population is infected with TB. In 2013, it caused 1.5 million deaths, and the incidence of drug resistance is increasing. TB's prevalence in low‐ and medium‐income countries means that new therapies must be accessed quickly and cheaply. Simple 1,2,3‐triazoles were assembled via click chemistry in high crude purity and in moderate to high yield, and serve as excellent starting points for development of potent therapies. For further details, see the Communication by Luke C. Henderson et al. on